LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | TGX221 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4117 | 4660 | 0.8825 | 0.8725 |
MDA-MB-231 | TGX221 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4099 | 4660 | 0.8785 | 0.8680 |
MDA-MB-231 | TGX221 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 4311 | 4660 | 0.9228 | 0.9154 |
MDA-MB-231 | TGX221 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 4251 | 4660 | 0.9106 | 0.9025 |
MDA-MB-231 | TGX221 | 10 | uM | LJP5 | 72 | hr | 1235 | 4077 | 4660 | 0.8742 | 0.8637 |
MDA-MB-231 | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4766 | 4660 | 1.0222 | 1.0228 |
MDA-MB-231 | GSK1059615 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3977 | 4405 | 0.9005 | 0.8836 |
MDA-MB-231 | GSK1059615 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4527 | 4660 | 0.9732 | 0.9724 |
MDA-MB-231 | GSK1059615 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 4126 | 4405 | 0.9358 | 0.9277 |
MDA-MB-231 | GSK1059615 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4112 | 4660 | 0.8817 | 0.8719 |
MDA-MB-231 | GSK1059615 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3933 | 4405 | 0.8920 | 0.8769 |
MDA-MB-231 | GSK1059615 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 2452 | 4660 | 0.5251 | 0.4258 |
MDA-MB-231 | GSK1059615 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2124 | 4405 | 0.4780 | 0.3129 |
MDA-MB-231 | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 1118 | 4660 | 0.2400 | -0.0524 |
MDA-MB-231 | GSK1059615 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1188 | 4405 | 0.2667 | -0.0500 |
MDA-MB-231 | GSK1059615 | 10 | uM | LJP5 | 72 | hr | 1235 | 518 | 4660 | 0.1105 | -0.3706 |
MDA-MB-231 | GSK1059615 | 10 | uM | LJP6 | 72 | hr | 1235 | 846 | 4405 | 0.1901 | -0.2070 |
MDA-MB-231 | Brivanib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4067 | 4660 | 0.8708 | 0.8583 |
MDA-MB-231 | Brivanib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4196 | 4660 | 0.8994 | 0.8910 |
MDA-MB-231 | Brivanib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4187 | 4660 | 0.8962 | 0.8861 |
MDA-MB-231 | Brivanib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 4270 | 4660 | 0.9136 | 0.9042 |
MDA-MB-231 | Brivanib | 3.33 | uM | LJP5 | 72 | hr | 1235 | 4181 | 4660 | 0.8965 | 0.8883 |
MDA-MB-231 | Brivanib | 10 | uM | LJP5 | 72 | hr | 1235 | 3080 | 4660 | 0.6610 | 0.6104 |
MDA-MB-231 | CHIR-99021 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3927 | 4405 | 0.8913 | 0.8782 |
MDA-MB-231 | CHIR-99021 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3769 | 4405 | 0.8550 | 0.8354 |